Antacids Market Companies Overview 2017 - 2025

The global antacids market features a large number of companies, both international as well as regional, which serve the global market through a large number of products varieties and brands. The level of competition is thus intense and the high focus of companies on new markets and growth opportunities is evident through the several strategic collaborations to have taken place in the market in the past years, observes Transparency Market Research in a recent report.

Some of the leading companies in the market are Reckitt Benckiser Group plc, AstraZeneca, Valeant Pharmaceuticals International Inc., Boehringer Ingelheim GmbH, Bayer AG, GlaxoSmithKline plc, Sanofi, Pfizer Inc., Johnson & Johnson, Sun Pharmaceuticals Ltd., Procter & Gamble, Dr. Reddy’s Laboratories Ltd., and Takeda Pharmaceutical Company Ltd.

Get PDF Sample Copy of Report: (Including TOC, List of Tables & Figures, Chart) : https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=32864

According to the report, the market is expected to exhibit a 3.7% CAGR from 2017 to 2025, rising to a valuation of US$18.7 bn by 2025.

Proton Pump Inhibitors Acquire Dominant Share in Overall Market

Of the key drug classes available in the global market, the segment of proton pump inhibitors is likely to acquire the dominant share in global revenue over the report’s forecast period. The segment also accounted for the dominant share in the overall market in 2016, thanks to their easy availability as over-the-counter (OTC) as well as prescription medicines and low cost.

REQUEST FOR COVID19 IMPACT ANALYSIS – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=32864

Over the forecast period, however, the segment of acid neutralizers is expected to emerge as the most lucrative segment owing to their vast usage for occasional acidity and heartburns and their availability in the form of several flavors and formulations. Geographically, the market in Europe accounted for the dominant share in the overall market owing to the vast rise in gastro-esophageal-reflux disorders in the region.

Rising Geriatric Population and Consecutive Rise in Gastroesophageal Reflux Conditions to Drive Market

The massive rise in the world’s population of geriatrics – people above the age of 60 years – has worked as one of the most favorable growth factors for the global antacids market as the demographic is highly vulnerable to peptic ulcers and gastroesophageal reflux disorders. Estimates suggest that the world geriatric population will rise to 923 mn by 2050 in Asia alone. This also suggests a potential for steady rise in demand for antacids to counter gastroesophageal reflux diseases and peptic ulcers in this population.

Buy Now Report : https://www.transparencymarketresearch.com/checkout.php?rep_id=32864<ype=S

The market is also expected to be driven due to the vast rise in prevalence of acidity and heartburn among the global population, thanks to unhealthy dietary habits, stressful lifestyles, lack of proper sleep, and lack of physical activities. The market is also likely to benefit from the widespread practice of self-medication in cases of acidity and occasional heartburns and the easy availability of a variety of over-the-counter antacids across the globe. However, concerns associated with the adverse health effects of prolonged use of antacids could hamper the growth of the market to a certain degree.

This review of the global antacids market is based on a recent market research report by Transparency Market Research, titled “Antacids Market (Drug Class – Proton Pump Inhibitor, H2 Antagonist, and Acid Neutralizers; Formulation Type – Tablet, Liquid, and Powder; Distribution Channel – Hospital Pharmacies and Retail Pharmacies) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017–2025.”

Read our Case study at : https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

For the study, the market has been segmented as follows:

Antacids Market, by Drug Class

Proton pump inhibitors
H2 antagonist
Acid neutralizers
Antacids Market, by Formulation Type

Tablet
Liquid
Powder
Others
Antacids Market, by Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Others
Antacids Market, by Region

North America
U.S.
Canada
Europe
U.K.
France
Germany
Italy
Spain
Rest of Europe
Asia Pacific
India
China
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
Saudi Arabia
Rest of Middle East & Africa
More Trending Reports by Transparency Market Research – 1. https://www.prnewswire.com/news-releases/global-hemorrhoid-treatment-devices-market-to-grow-at-over-4-6-cagr-from-2018-to-2026-transparency-market-research-301001722.html

2. https://www.biospace.com/article/wound-irrigation-solution-market-detailed-analysis-and-forecast-by-2028/

Contact

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States

Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.”

This release was published on openPR.